Depolarization controls TRAIL-sensitization and tumor-selective killing of cancer cells: Crosstalk with ROS

Frontiers in Oncology

Volumn 4 MAY, Issue , 2014, Pages

  Suzuki Karasaki, Yoshihiro ^a,b   Suzuki Karasaki, Miki ^b   Uchida, Mayumi ^b   Ochiai, Toyoko ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Aapoptosis; Depolarization; Endoplasmic reticulum stress; Oxidative stress; ROS; Sensitization; TRAIL; Tumor selective killing

Indexed keywords

ALLYL SULFIDE; BEVACIZUMAB; CAPSAICIN; CARBOPLATIN; CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CONATUMUMAB; CYTOCHROME C; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DULANERMIN; EPIGALLOCATECHIN GALLATE; HERBACEOUS AGENT; MAPATUMUMAB; PACLITAXEL; PANCRATISTATIN; PIPERLONGUMINE; PROTEIN BCL 2; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE; TIGATUZUMAB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; UNCLASSIFIED DRUG; UNINDEXED DRUG; WOGONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CYTOTOXICITY; DEPOLARIZATION; DNA FRAGMENTATION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; GLIOMA; HUMAN; LUNG NON SMALL CELL CANCER; MELANOMA; MITOCHONDRIAL PERMEABILITY; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; PURKINJE CELL; REPOLARIZATION; REVIEW; SENSITIZATION; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

EID: 84904618232     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00128     Document Type: Review

References (123)

1. LeBlanc HN, Ashkenazi A. Apo2L/TRAIL and its death and decoy. Cell Death Differ (2003) 10:66-75. doi: 10.1038/sj.cdd.4401187
2. Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer (2008) 8:782-98. doi:10.1038/nrc2465
3. Wang S. The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene (2008) 27:6207-15. doi:10.1038/onc.2008.298
4. Sayers TJ. Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol Immunother (2011) 60:1173-80. doi:10.1007/s00262-011-1008-4
5. Brost S, Zimmermann A, Koschny R, Sykora J, Stremmel W, Schirmacher P, et al. Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection. Pathol Res Pract (2014) 210:83-91. doi:10.1016/j.prp.2013.10.005
6. Badmann A, Langsch S, Keogh A, Brunner T, Kaufmann T, Corazza N. TRAIL enhances paracetamol-induced liver sinusoidal endothelial cell death in a Bim- and Bid-dependent manner. Cell Death Dis (2012) 20(3):e447. doi:10.1038/cddis.2012.185
7. Cazanave SC, Mott JL, Bronk SF, Werneburg NW, Fingas CD, Meng XW, et al. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J Biol Chem (2011) 286:39336-48. doi:10.1074/jbc.M111.280420
8. Corazza N, Jakob S, Schaer C, Frese S, Keogh A, Stroka D, et al. TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. J Clin Invest (2006) 116:2493-9. doi:10.1172/JCI27726
9. Förster A, Preussner LM, Seeger JM, Rabenhorst A, Kashkar H, Mrowietz U, et al. Dimethylfumarate induces apoptosis in human mast cells. Exp Dermatol (2013) 22:719-24. doi:10.1111/exd.12247
10. Dyer MJ, MacFarlane M, Cohen GM. Barriers to effective TRAIL-targeted therapy of malignancy. J Clin Oncol (2007) 25(28):4505-6.
11. Dimberg LY, Anderson CK, Camidge R, Behbakht K, Thorburn A, Ford HL. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics. Oncogene (2013) 32:1341-50. doi:10.1038/onc.2012.164
12. McCarthy JV, Cotter TG. Cell shrinkage and apoptosis: a role for potassium and sodium ion efflux. Cell Death Differ (1997) 4:756-70. doi:10.1038/sj.cdd.4400296
13. Lang F, Föller M, Lang K, Lang P, Ritter M, Vereninov A, et al. Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol (2007) 428:209-25. doi:10.1016/S0076-6879(07)28011-5
14. Bortner CD, Gomez-Angelats M, Cidlowski JA. Plasma membrane depolarization without repolarization is an early molecular event in anti-Fas-induced apoptosis. J Biol Chem (2001) 276:4304-14. doi:10.1074/jbc.M005171200
15. Yin W, Li X, Feng S, Cheng W, Tang B, Shi YL, et al. Plasma membrane depolarization and Na,K-ATPase impairment induced by mitochondrial toxins augment leukemia cell apoptosis via a novel mitochondrial amplification mechanism. Biochem Pharmacol (2009) 78:191-202. doi:10.1016/j.bcp.2009.03.025
16. Nolte F, Friedrich O, Rojewski M, Fink RH, Schrezenmeier H, Körper S. Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells. FEBS Lett (2004) 578:85-9. doi:10.1016/j.febslet.2004.10.075
17. Ghoumari AM, Piochon C, Tomkiewicz C, Eychenne B, Levenes C, Dusart I, et al. Neuroprotective effect of mifepristone involves neuron depolarization. FASEB J (2006) 20:1377-86. doi:10.1096/fj.05-5832com
18. Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res (2006) 66:5867-74. doi:10.1158/0008-5472.CAN-05-3544
19. Suzuki Y, Inoue T, Murai M, Suzuki-Karasaki M, Ochiai T, Ra C. Depolarization potentiates TRAIL-induced apoptosis in human melanoma cells: role for ATP-sensitive K+ channels and endoplasmic reticulum stress. Int J Oncol (2012) 41:465-75. doi:10.3892/ijo.2012.1483
20. Inoue T, Suzuki-Karasaki Y. Mitochondrial superoxide mediates mitochondrial and endoplasmic reticulum dysfunctions in TRAIL-induced apoptosis in Jurkat cells. Free Radic Biol Med (2013) 61:273-84. doi:10.1016/j.freeradbiomed.2013.04.020
21. Suzuki-Karasaki M, Ochiai T, Suzuki-Karasaki Y. Crosstalk between mitochondrial ROS and depolarization in the potentiation of TRAIL-induced apoptosis in human tumor cells. Int J Oncol (2014) 44:616-28. doi:10.3892/ijo.2013.2215
22. Murai M, Inoue T, Suzuki-Karasaki M, Ochiai T, Ra C, Nishida S, et al. Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis. Int J Oncol (2012) 41:2029-37. doi:10.3892/ijo.2012.1656
23. Tochigi M, Inoue T, Suzuki-Karasaki M, Ochiai T, Ra C, Suzuki-Karasaki Y. Hydrogen peroxide induces cell death in human TRAIL-resistant melanoma through intracellular superoxide generation. Int J Oncol (2013) 42:863-72. doi:10.3892/ijo.2013.1769
24. Chen LH, Jiang CC, Kiejda KA, Wang YF, Thorne RF, Zhang XD, et al. Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response. Carcinogenesis (2007) 28:2328-36. doi:10.1093/carcin/bgm173
25. Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, et al. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Cancer Res (2007) 67:5880-8. doi:10.1158/0008-5472.CAN-07-0213
26. Liu H, Jiang CC, Lavis CJ, Croft A, Dong L, Tseng HY, et al. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2. Mol Cancer (2009) 8:122. doi:10.1186/1476-4598-8-122
27. Hail N Jr. Mitochondria: a novel target for the chemoprevention of cancer. Apoptosis (2005) 10:687-705. doi:10.1007/s10495-005-0792-8
28. Brenner C, Grimm S. The permeability transition pore complex in cancer cell death. Oncogene (2006) 25:4744-56. doi:10.1038/sj.onc.1209609
29. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell (2004) 116:205-19. doi:10.1016/S0092-8674(04)00046-7
30. Halestrap AP, Brennerb C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem (2003) 10:1507-25. doi:10.2174/0929867033457278
31. Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta (2009) 1787:1395-401. doi:10.1016/j.bbabio.2009.06.009
32. Zhivotovsky B, Galluzzi L, Kepp O, Kroemer G. Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery. Cell Death Differ (2009) 16:1419-25. doi:10.1038/cdd.2009.118
33. Dalla Via L, García-Argáez AN, Martínez-Vázquez M, Grancara S, Martinis P, Toninello A. Mitochondrial permeability transition as target of anticancer drugs. Curr Pharm Des (2014) 20:223-44.
34. Gogvadze V. Targeting mitochondria in fighting cancer. Curr Pharm Des (2011) 17:4034-46.
35. Boyce M, Yuan J. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ (2006) 13:363-73. doi:10.1038/sj.cdd.4401817
36. Szegezdi E, Fitzgerald U, Samali A. Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann N Y Acad Sci (2003) 1010:186-94. doi:10.1196/annals.1299.032
37. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol (2004) 14:20-8. doi:10.1016/j.tcb.2003.11.001
38. Groenendyk J, Michalak M. Endoplasmic reticulum quality control and apoptosis. Acta Biochim Pol (2005) 52:381-95.
39. Martin S, Hill DS, Paton JC, Paton AW, Birch-Machin MA, Lovat PE, et al. Targeting GRP78 to enhance melanoma cell death. Pigment Cell Melanoma Res (2010) 23:675-82. doi:10.1111/j.1755-148X.2010.00731.x
40. Shen HM, Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J (2006) 20:1589-98. doi:10.1096/fj.05-5603rev
41. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med (2010) 48:749-62. doi:10.1016/j.freeradbiomed.2009.12.022
42. Suzuki Y, Ono Y, Hirabayashi Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett (1998) 425:209-12. doi:10.1016/S0014-5793(98)00228-2
43. Miñana JB, Gómez-Cambronero L, Lloret A, Pallardó FV, Del Olmo J, Escudero A, et al. Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism. Hepatology (2002) 35:1205-14. doi:10.1053/jhep.2002.32969
44. Sato T, Machida T, Takahashi S, Iyama S, Sato Y, Kuribayashi K, et al. Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol (2004) 173:285-96. doi:10.4049/jimmunol.173.1.285
45. Reinehr R, Becker S, Eberle A, Grether-Beck S, Häussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem (2005) 280:27179-94. doi:10.1074/jbc.M414361200
46. Goossens V, Stangé G, Moens K, Pipeleers D, Grooten J. Regulation of tumor necrosis factor-induced, mitochondria- and reactive oxygen species-dependent cell death by the electron flux through the electron transport chain complex I. Antioxid Redox Signal (1999) 1:285-95. doi:10.1089/ars.1999.1.3-285
47. Kim YS, Morgan MJ, Choksi S, Liu ZG. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell (2007) 26:675-87. doi:10.1016/j.molcel.2007.04.021
48. Mellier G, Pervaiz S. The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS). Free Radic Res (2012) 46:996-1003. doi:10.3109/10715762.2012.690514
49. Shenoy K, Wu Y, Pervaiz S. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors. Cancer Res (2009) 69:1941-50. doi:10.1158/0008-5472.CAN-08-1996
50. Lee DH, Rhee JG, Lee YJ. Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin. Br J Pharmacol (2009) 157:1189-202. doi:10.1111/j.1476-5381.2009.00245.x
51. Das A, Banik NL, Ray SK. Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer (2007) 110:1083-95. doi:10.1002/cncr.22888
52. Powolny AA, Singh SV. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett (2008) 269:305-14. doi:10.1016/j.canlet.2008.05.027
53. Pallepati P, Averill-Bates DA. Activation of ER stress and apoptosis by hydrogen peroxide in HeLa cells: protective role of mild heat preconditioning at 40°C. Biochim Biophys Acta (2011) 1813:1987-99. doi:10.1016/j.bbamcr.2011.07.021
54. Delhalle S, Deregowski V, Benoit V, Merville MP, Bours V. NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene (2002) 21:3917-24. doi:10.1038/sj.onc.1205489
55. Perez-Cruz I, Carcamo JM, Golde DW. Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood (2003) 102:336-43. doi:10.1182/blood-2002-11-3559
56. Chen Y, Azad MB, Gibson SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ (2009) 16:1040-52. doi:10.1038/cdd.2009.49
57. Wang Y, Nartiss Y, Steipe B, McQuibban GA, Kim PK. ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy (2012) 8:1462-76. doi:10.4161/auto.21211
58. Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer Res (2014) 74:647-51. doi:10.1158/0008-5472.CAN-13-2966
59. Gewirtz DA. Cytoprotective and nonprotective autophagy in cancer therapy. Autophagy (2013) 9:1263-5. doi:10.4161/auto.25233
60. Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J (2012) 441:523-40. doi:10.1042/BJ20111451
61. Chaabane W, User SD, El-Gazzah M, Jaksik R, Sajjadi E, Rzeszowska-Wolny J, et al. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer. Arch Immunol Ther Exp (2013) 61:43-58. doi:10.1007/s00005-012-0205-y
62. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med (2002) 195:59-70. doi:10.1084/jem.20010659
63. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol (1994) 55:253-8.
64. Suzuki Y, Yoshimaru T, Inoue T, Ra C. Discrete generations of intracellular hydrogen peroxide and superoxide in antigen-stimulated mast cells: reciprocal regulation of store-operated Ca2+ channel activity. Mol Immunol (2009) 46:2200-9. doi:10.1016/j.molimm.2009.04.013
65. Mukhopadhyay P, Rajesh M, Yoshihiro K, Haskó G, Pacher P. Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Commun (2007) 358:203-8. doi:10.1016/j.bbrc.2007.04.106
66. Batinic-Haberle I, Cuzzocrea S, Rebouças JS, Ferrer-Sueta G, Mazzon E, Di Paola R, et al. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy. Free Radic Biol Med (2009) 46:192-201. doi:10.1016/j.freeradbiomed.2008.09.042
67. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Cancer Res (2005) 65:7436-45. doi:10.1158/0008-5472.CAN-04-2628
68. Jia L, Kelsey SM, Grahn MF, Jiang XR, Newland AC. Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor alpha-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines. Blood (1996) 87:2401-10.
69. Guidarelli A, Cerioni L, Cantoni O. Inhibition of complex III promotes loss of Ca2+ dependence for mitochondrial superoxide formation and permeability transition evoked by peroxynitrite. J Cell Sci (2007) 120:1908-14. doi:10.1242/jcs.003228
70. Skulachev VP. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett (1996) 397:7-10. doi:10.1016/0014-5793(96)00989-1
71. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev (2007) 39:443-55. doi:10.1080/03602530701468516
72. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis (2007) 12:913-22. doi:10.1007/s10495-007-0756-2
73. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Moreno-Sánchez R. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med (2010) 31:29-59. doi:10.1016/j.mam.2009.12.006
74. Ott M, Zhivotovsky B, Orrenius S. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ (2007) 14:1243-7. doi:10.1038/sj.cdd.4402135
75. Petit JM, Maftah A, Ratinaud MH, Julien R. 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem (1992) 209:267-73. doi:10.1111/j.1432-1033.1992.tb17285.x
76. Griffith TS, Rauch CT, Smolak PJ, Waugh JY, Boiani N, Lynch DH, et al. Functional analysis of TRAIL receptors using monoclonal antibodies. J Immunol (1999) 162:2597-605.
77. Georgakis GV, Li Y, Humphreys R, Andreeff M, O'Brien S, Younes M, et al. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Br J Haematol (2005) 130:501-10. doi:10.1111/j.1365-2141.2005.05656.x
78. Kroemer G, Petit P, Zamzami N, Vayssière JL, Mignotte B. The biochemistry of programmed cell death. FASEB J (1995) 9:1277-87.
79. Al-Mehdi AB, Zhao G, Dodia C, Tozawa K, Costa K, Muzykantov V, et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res (1998) 83:730-7. doi:10.1161/01.RES.83.7.730
80. Zhang Q, Matsuzaki I, Chatterjee S, Fisher AB. Activation of endothelial NADPH oxidase during normoxic lung ischemia is KATP channel dependent. Am J Physiol Lung Cell Mol Physiol (2005) 289:L954-61. doi:10.1152/ajplung.00210.2005
81. Chatterjee S, Browning EA, Hong N, DeBolt K, Sorokina EM, Liu W, et al. Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. Am J Physiol Heart Circ Physiol (2012) 302:H105-14. doi:10.1152/ajpheart.00298.2011
82. Bonner MY, Arbiser JL. Targeting NADPH oxidases for the treatment of cancer and inflammation. Cell Mol Life Sci (2012) 69:2435-42. doi:10.1007/s00018-012-1017-2
83. Jones KJ, Chetram MA, Bethea DA, Bryant LK, Odero-Marah V, Hinton CV. Cysteine (C)-X-C receptor 4 regulates NADPH oxidase-2 during oxidative stress in prostate cancer cells. Cancer Microenviron (2013) 6:277-88. doi:10.1007/s12307-013-0136-0
84. Maraldi T, Prata C, Caliceti C, Vieceli Dalla Sega F, Zambonin L, Fiorentini D, et al. VEGF-induced ROS generation from NAD(P)H oxidases protects human leukemic cells from apoptosis. Int J Oncol (2010) 36:1581-9.
85. Yin W, Cheng W, Shen W, Shu L, Zhao J, Zhang J, et al. Impairment of Na(+),K(+)-ATPase in CD95(APO-1)-induced human T-cell leukemia cell apoptosis mediated by glutathione depletion and generation of hydrogen peroxide. Leukemia (2007) 21:1669-78. doi:10.1038/sj.leu.2404791
86. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res (1991) 51:794-8.
87. Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J (2009) 418:29-37. doi:10.1042/BJ20081258
88. Hu Y, Rosen DG, Zhou Y, Feng L, Yang G, Liu J, et al. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J Biol Chem (2005) 280:39485-92. doi:10.1074/jbc.M503296200
89. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature (2005) 436:123-7. doi:10.1038/nature03688
90. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science (1997) 275:1649-52. doi:10.1126/science.275.5306.1649
91. Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB, Winkler T, et al. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem (2000) 275:24273-8. doi:10.1074/jbc.M002094200
92. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell (2002) 9:1031-44. doi:10.1016/S1097-2765(02)00520-8
93. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans (2003) 31:1441-4. doi:10.1042/BST0311441
94. Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D, et al. Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood (2005) 105:1717-23. doi:10.1182/blood-2004-03-0849
95. Naughton R, Quiney C, Turner SD, Cotter TG. Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway. Leukemia (2009) 23:1432-40. doi:10.1038/leu.2009.49
96. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature (2000) 407:390-5. doi:10.1038/35030140
97. Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood (2003) 101:4098-104. doi:10.1182/blood-2002-08-2512
98. Yu R, Mandlekar S, Harvey KJ, Ucker DS, Kong AN. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res (1998) 58:402-8.
99. Zhang Y, Tang L, Gonzalez V. Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther (2003) 2:1045-52.
100. Wu SJ, Ng LT, Lin CC. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. Eur J Pharmacol (2005) 518:96-106. doi:10.1016/j.ejphar.2005.06.021
101. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell (2006) 10:241-52. doi:10.1016/j.ccr.2006.08.009
102. Wu XJ, Hua X. Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol Ther (2007) 6:646-7. doi:10.4161/cbt.6.5.4092
103. Baumann S, Fas SC, Giaisi M, Müller WW, Merling A, Gülow K, et al. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. Blood (2008) 111:2354-63. doi:10.1182/blood-2007-06-096198
104. Wei L, Lu N, Dai Q, Rong J, Chen Y, Li Z, et al. Different apoptotic effects of wogonin via induction of H2O2 generation and Ca2+ overload in malignant hepatoma and normal hepatic cells. J Cell Biochem (2010) 111:1629-41. doi:10.1002/jcb.22898
105. Tsai CF, Yeh WL, Huang SM, Tan TW, Lu DY. Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells. Int J Mol Sci (2012) 13:9877-92. doi:10.3390/ijms13089877
106. Yang WH, Fong YC, Lee CY, Jin TR, Tzen JT, Li TM, et al. Epigallocatechin-3-gallate induces cell apoptosis of human chondrosarcoma cells through apoptosis signal-regulating kinase 1 pathway. J Cell Biochem (2011) 112:1601-11. doi:10.1002/jcb.23072
107. Macho A, Calzado MA, Muñoz-Blanco J, Gómez-Díaz C, Gajate C, Mollinedo F, et al. Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ (1999) 6:155-65. doi:10.1038/sj.cdd.4400465
108. Pramanik KC, Boreddy SR, Srivastava SK. Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. PLoS One (2011) 6:e20151. doi:10.1371/journal.pone.0020151
109. McLachlan A, Kekre N, McNulty J, Pandey S. Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis (2005) 10:619-30. doi:10.1007/s10495-005-1896-x
110. Griffin C, McNulty J, Pandey S. Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells. Int J Oncol (2011) 38:1549-56. doi:10.3892/ijo.2011.977
111. Griffin C, Karnik A, McNulty J, Pandey S. Pancratistatin selectively targets cancer cell mitochondria and reduces growth of human colon tumor xenografts. Mol Cancer Ther (2011) 10:57-68. doi:10.1158/1535-7163.MCT-10-0735
112. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature (2011) 475:231-4. doi:10.1038/nature10167
113. Karmakar S, Banik NL, Patel SJ, Ray SK. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Apoptosis (2007) 12:671-84. doi:10.1007/s10495-006-0024-x
114. Gosslau A, Chen M, Ho CT, Chen KY. A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts. Br J Cancer (2005) 92:513-21.
115. Chen V, Staub RE, Fong S, Tagliaferri M, Cohen I, Shtivelman E. Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS. PLoS One (2012) 7:e30300. doi:10.1371/journal.pone.0030300
116. Basile V, Belluti S, Ferrari E, Gozzoli C, Ganassi S, Quaglino D, et al. bis-Dehydroxy-Curcumin triggers mitochondrial-associated cell death in human colon cancer cells through ER-stress induced autophagy. PLoS One (2013) 8:e53664. doi:10.1371/journal.pone.0053664
117. Pérez-Ortiz JM, Tranque P, Burgos M, Vaquero CF, Llopis J. Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxide. Mol Pharmacol (2007) 72:407-17. doi:10.1124/mol.106.032458
118. Jangamreddy JR, Ghavami S, Grabarek J, Kratz G, Wiechec E, Fredriksson BA, et al. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. Biochim Biophys Acta (2013) 1833:2057-69. doi:10.1016/j.bbamcr.2013.04.011
119. Pérez-Ortiz JM, Tranque P, Vaquero CF, Domingo B, Molina F, Calvo S, et al. Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma. J Biol Chem (2004) 279:8976-85. doi:10.1074/jbc.M308518200
120. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci (2007) 120:4155-66. doi:10.1242/jcs.011163
121. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ (2008) 15:171-82. doi:10.1038/sj.cdd.4402233
122. Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, et al. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS One (2011) 6:e21077. doi:10.1371/journal.pone.0021077
123. Hu H, Jiang C, Schuster T, Li GX, Daniel PT, Lü J. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway. Mol Cancer Ther (2006) 5:1873-82. doi:10.1158/1535-7163.MCT-06-0063